VICC Cancer Survivorship Celebration set for June 8

Music will set the tone for Vanderbilt-Ingram Cancer Center’s annual Cancer Survivorship Celebration for patients, friends and families.

PET probe detects dying tumor cells

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.

Photo: Head and neck cancer screening

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.

VICC debuts novel neuroendocrine tumor treatment

A retired elementary school principal has become the first patient at Vanderbilt-Ingram Cancer Center to receive an investigational cancer therapy for the treatment of his neuroendocrine tumor.

VICC research takes center stage at national meeting

Research led by Joan Garrett, Ph.D., research instructor in Hematology/Oncology, reveals a molecular mechanism that may explain why some forms of breast cancer become resistant to therapy.